Takeda Pharmaceuticals America, Inc.Usage: ROZEREM® is indicated for the treatment of insomnia, specifically for difficulty with sleep onset. Clinical trials supporting its efficacy lasted up to six months, evaluating sleep latency at various points during treatment in both adults and the elderly.